ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $685,000 | -12.4% | 43,161 | +20.5% | 0.00% | – |
| Q4 2021 | $782,000 | -47.4% | 35,821 | -28.0% | 0.00% | -100.0% |
| Q3 2021 | $1,487,000 | -45.1% | 49,734 | -18.7% | 0.00% | -50.0% |
| Q2 2021 | $2,710,000 | -39.6% | 61,197 | -39.5% | 0.00% | -33.3% |
| Q1 2021 | $4,485,000 | +77.5% | 101,082 | +119.4% | 0.00% | +50.0% |
| Q4 2020 | $2,527,000 | +704.8% | 46,075 | +235.2% | 0.00% | – |
| Q3 2020 | $314,000 | +8.3% | 13,747 | -0.7% | 0.00% | – |
| Q2 2020 | $290,000 | +93.3% | 13,843 | +29.1% | 0.00% | – |
| Q1 2020 | $150,000 | -72.6% | 10,724 | -55.4% | 0.00% | – |
| Q4 2019 | $548,000 | +103.7% | 24,062 | +4.3% | 0.00% | – |
| Q3 2019 | $269,000 | +44.6% | 23,064 | +85.9% | 0.00% | – |
| Q2 2019 | $186,000 | – | 12,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |